Stock Spotlight Archives - Page 195 of 379

FridayApr 09, 2021 2:42 pm

QualityStocksNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Collaborates to Expand into ‘Ideal Play’ Canadian Marketplace

TAAT(TM) (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has entered a deal to take its flagship product — TAAT(TM), a tobacco-free, nicotine-free cigarette — into Canada. On the heels of record-breaking sales of its online and on-the-ground retail launch in Ohio, the company has finalized a memorandum of understanding with Christina Lake Cannabis Corp. (CSE: CLC) to develop and distribute its proprietary product in the Canadian market. “We are very pleased to have partnered with CLC, giving us the opportunity to bring TAAT to legal-aged smokers in Canada, many of whom have shown great enthusiasm about the product,” stated TAAT CEO…

FridayApr 09, 2021 1:20 pm

QualityStocksNewsBreaks – Splash Beverage Group Inc. (SBEV) Posts Consistent Growth Backed by Acquisitions, Experienced Management

Splash Beverage Group (OTCQB: SBEV), a portfolio company of successful beverage brands, has diversified into alcoholic and non-alcoholic drink segments through acquisitions, a move that has seen it report significant sales revenue growth. “The measured growth initiatives are showing up in the financials, with sales starting in Q1 2020 at $112,003 and rising to $612,308 in Q2, then $1.01 million in Q3 and $1.24 million in Q4 for $2.98 million for 2020,” reads an article detailing the tremendous growth. The company’s management is credited for being behind this upward movement in revenue. “Splash also made a few key leadership moves…

FridayApr 09, 2021 1:02 pm

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Targets Investments that Complement, Further Business Goals

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), an innovative genetics-based cannabis company located in Canada, recently acquired a large tract of land (250 acres) in one of Canada’s most productive and intensively farmed areas. “The company is also in the process of completing its 20,000-square-foot cultivation facility in Lake County, B.C., that will allow it to cycle through an elite line of high-grade cultivars across roughly 7,600 square feet of cultivation space,” reads an article discussing Pac Roots’ recent moves. The land and cultivation facility are part of a growing list of investments, given that the company recently completed…

FridayApr 09, 2021 12:08 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Eyes Expansion of AI-Driven Clinical Models

Predictive Oncology (NASDAQ: POAI) has set sights on other cancers after completing its data generation milestones in a collaborative study with UPMC-Magee Women Hospital. With the comprehensive genomic and transcriptomic sequencing of patient samples now complete, thanks to the study, and patient outcome data having been obtained from UPMC-Magee, “these data will now be used to drive POAI’s AI models of ovarian cancer and their internal ovarian cancer drug re-purposing project.” This is according to an article detailing the matter. “‘The successful generation of high-quality genomic and transcriptomic data from archived materials at Helomics, together with the gathering of historical…

ThursdayApr 08, 2021 2:19 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin to Demonstrate Effectiveness vs. Established Chemotherapy Drug in Phase 2 Trial

CNS Pharmaceuticals (NASDAQ: CNSP) continues to aggressively pursue FDA approval for its lead drug candidate, Berubicin. The novel candidate is the first anthracycline that appears to be able to cross the blood-brain barrier to combat tumors — stepping up its cancer-fighting potential. Berubicin was the subject of a Phase 1 safety trial conducted by Reata Pharmaceuticals approximately 15 years ago. One of the trial participants has remained alive and cancer-free as of the most recent evaluation late last year, while two other patients in the small study saw reductions of greater than 25% (one being an 80% reduction) in the…

ThursdayApr 08, 2021 1:47 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Creates Win-Win Solution for Hospitals, Patients

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, has developed a solution set to lower the cost of treating bladder cancer and also help hospitals save money. As a result, Imagin will create a win-win situation for every party involved. The i/Blue(TM) Imaging System, Imagin’s proprietary solution, achieves this in two ways. “By displaying the blue light image that shows the highlighted cancer cells alongside the white light image that shows the full landscape of the bladder, the i/Blue Imaging System will provide surgeons with improved visualization to locate and resect tumors. The overall result is a reduction…

ThursdayApr 08, 2021 1:09 pm

QualityStocksNewsBreaks – Healthtech Solutions Inc. (HLTT) Facilitates Remote Diagnosis with Subsidiary Technology

Healthtech Solutions (OTC: HLTT) has, through its wholly owned subsidiary, MediScan, developed a point-of-care ultrasound (“POCUS”) solution that alleviates the need for patients to visit hospitals for timely care, especially in emergencies. MediScan specializes in medical imaging products for acute, emergency medical situations wherein patients require quick and accurate assessment that comes with high-quality ultrasound. An article on Healthtech’s subsidiary tech reads, “Technology such as MediScan, which provides highly precise HD scans in under three minutes, can minimize the time before diagnosis and start of treatment. MediScan’s proprietary technology uses scans from ultrasound machines to reconstruct the analog two-dimensional grayscale…

WednesdayApr 07, 2021 1:06 pm

QualityStocksNewsBreaks – Healthy Extracts Inc. (HYEX) Shares Promising Clinical Study Results for HERHEART(TM), Fuel4Thought(TM) Brain Booster

Healthy Extracts (OTCQB: HYEX) is engaged in proprietary research and development of natural plant-based formulations, sales, and distribution of cardiovascular and neuro products. HYEX recently announced promising clinical study results for two of its subsidiary companies’ leading products: BergaMet North America’s HERHEART(TM) and Ultimate Brain Nutrients’ Fuel4Thought(TM) Brain Booster. “HERHEART(TM) is an exclusive natural supplement that is scientifically formulated specifically for women to support cardiovascular health, including perimenopausal symptoms. The study was conducted in 35 postmenopausal women with sexual dysfunction at the University Magna Graecia of Caranzaro in Italy. Results indicated that patients who were administered HERHEART(TM) reported a 40%…

MondayApr 05, 2021 1:47 pm

QualityStocksNewsBreaks – United Medical Equipment Business Solutions Network Inc. Poised Amid Demand for Rapid Testing Kits

United Medical Equipment (“UME,” “UMEBSNI”), a company offering rapid COVID-19 testing kits, looks positioned to benefit from the high demand for its products. The demand arises from expert recommendations that identifying those infected through rapid testing could help curb the virus and prevent the emergence of new variants. An article about these developments reads, “‘Testing is actually more important now than it was eight months ago because of the high contagiousness rate of these new variants,’ Mara Aspinall, a professor of health practice at Arizona State University, said in a recent interview for NPR. ‘It is critical to stop these…

Site Search

Company Search

Category: Stock Spotlight